Search research articles
Contact Us
Filters
Showing results (61-70 of 167) with videos related to
Page
of 17
Sort By:
Antimicrobial Agents and Chemotherapy
|
March 2, 2021
Population pharmacokinetics of dalbavancin and dosing consideration for optimal treatment of adult patients with staphylococcal osteoarticular infections
Pier Giorgio Cojutti, Matteo Rinaldi, Eleonora Zamparini, et al.
Antimicrobial Agents and Chemotherapy
|
October 18, 2021
Reply to Baklouti et al., "Why Is It Desirable To Do the External Evaluation of a Population Pharmacokinetic Model?"
Pier Giorgio Cojutti, Matteo Rinaldi, Eleonora Zamparini, et al.
Journal of Chromatography. A
|
April 7, 2007
An anion-exchange high-performance liquid chromatography method coupled to total organic carbon determination for the analysis of water-soluble organic aerosols
Valeriana Mancinelli, Matteo Rinaldi, Emanuela Finessi, et al.
Infectious Disease Reports
|
February 24, 2022
Successful Treatment of Bacteremia and Ventilator-Associated Pneumonia Caused by KPC/OXA-48-like <i>Klebsiella pneumoniae</i> Co-Producer with a Continuous Infusion of High-Dose Meropenem Plus Fosfomycin Guided by Real-Time Therapeutic Drug Monitoring
Pier Giorgio Cojutti, Giacomo Fornaro, Milo Gatti, et al.
European Journal of Pediatrics
|
August 4, 2022
Is acidemia at birth a risk factor for functional gastrointestinal disorders?
Flavia Indrio, Flavia Marchese, Matteo Rinaldi, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
July 29, 2023
Does therapeutic drug monitoring (TDM) of trough concentrations suffice for optimizing preemptive therapy with ganciclovir of cytomegalovirus infections in non-renal solid organ transplant recipients?
Milo Gatti, Matteo Rinaldi, Luciano Potena, et al.
The Journal of Antimicrobial Chemotherapy
|
March 24, 2025
A pre-post quasi-experimental study of the impact of TDM-guided aggressive pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftolozane/tazobactam monotherapy in treating severe Pseudomonas aeruginosa infections: a strategy useful for raising the bar?
Milo Gatti, Matteo Rinaldi, Cecilia Bonazzetti, et al.
Antimicrobial Agents and Chemotherapy
|
October 29, 2025
Keeping the horse with the cart: are we underdosing tazobactam even when using continuous-infusion ceftolozane/tazobactam for effectively preventing resistance development by ESBL-producing Enterobacterales?
Manjunath P Pai, Pier Giorgio Cojutti, Milo Gatti, et al.
The Science of the Total Environment
|
April 8, 2014
On the water-soluble organic nitrogen concentration and mass size distribution during the fog season in the Po Valley, Italy
Guillermo Montero-Martínez, Matteo Rinaldi, Stefania Gilardoni, et al.
Antimicrobial Agents and Chemotherapy
|
September 22, 2025
Targeting <i>Pseudomonas aeruginosa</i> resistance at the exposure frontier: a population PK/PD blueprint for ceftolozane/tazobactam continuous infusion
Pier Giorgio Cojutti, Manjunath P Pai, Milo Gatti, et al.
Page
of 17
Search research articles
Search
Showing results (61-70 of 167) with videos related to
Sort By:
Page
of 17
Antimicrobial Agents and Chemotherapy
|
March 2, 2021
Population pharmacokinetics of dalbavancin and dosing consideration for optimal treatment of adult patients with staphylococcal osteoarticular infections
Pier Giorgio Cojutti, Matteo Rinaldi, Eleonora Zamparini, et al.
Antimicrobial Agents and Chemotherapy
|
October 18, 2021
Reply to Baklouti et al., "Why Is It Desirable To Do the External Evaluation of a Population Pharmacokinetic Model?"
Pier Giorgio Cojutti, Matteo Rinaldi, Eleonora Zamparini, et al.
Journal of Chromatography. A
|
April 7, 2007
An anion-exchange high-performance liquid chromatography method coupled to total organic carbon determination for the analysis of water-soluble organic aerosols
Valeriana Mancinelli, Matteo Rinaldi, Emanuela Finessi, et al.
Infectious Disease Reports
|
February 24, 2022
Successful Treatment of Bacteremia and Ventilator-Associated Pneumonia Caused by KPC/OXA-48-like <i>Klebsiella pneumoniae</i> Co-Producer with a Continuous Infusion of High-Dose Meropenem Plus Fosfomycin Guided by Real-Time Therapeutic Drug Monitoring
Pier Giorgio Cojutti, Giacomo Fornaro, Milo Gatti, et al.
European Journal of Pediatrics
|
August 4, 2022
Is acidemia at birth a risk factor for functional gastrointestinal disorders?
Flavia Indrio, Flavia Marchese, Matteo Rinaldi, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
July 29, 2023
Does therapeutic drug monitoring (TDM) of trough concentrations suffice for optimizing preemptive therapy with ganciclovir of cytomegalovirus infections in non-renal solid organ transplant recipients?
Milo Gatti, Matteo Rinaldi, Luciano Potena, et al.
The Journal of Antimicrobial Chemotherapy
|
March 24, 2025
A pre-post quasi-experimental study of the impact of TDM-guided aggressive pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftolozane/tazobactam monotherapy in treating severe Pseudomonas aeruginosa infections: a strategy useful for raising the bar?
Milo Gatti, Matteo Rinaldi, Cecilia Bonazzetti, et al.
Antimicrobial Agents and Chemotherapy
|
October 29, 2025
Keeping the horse with the cart: are we underdosing tazobactam even when using continuous-infusion ceftolozane/tazobactam for effectively preventing resistance development by ESBL-producing Enterobacterales?
Manjunath P Pai, Pier Giorgio Cojutti, Milo Gatti, et al.
The Science of the Total Environment
|
April 8, 2014
On the water-soluble organic nitrogen concentration and mass size distribution during the fog season in the Po Valley, Italy
Guillermo Montero-Martínez, Matteo Rinaldi, Stefania Gilardoni, et al.
Antimicrobial Agents and Chemotherapy
|
September 22, 2025
Targeting <i>Pseudomonas aeruginosa</i> resistance at the exposure frontier: a population PK/PD blueprint for ceftolozane/tazobactam continuous infusion
Pier Giorgio Cojutti, Manjunath P Pai, Milo Gatti, et al.
Page
of 17